Podcasts about improve diagnosis

Helene M. Epstein is not here to make friends with the healthcare system. She's here to dismantle the bullshit, one catastrophic medical error at a time. A marketing agency veteran turned patient safety firebrand, Helene's journey from copywriter to cancer misdiagnosis survivor, to “badass queen of patient safety,” is one hell of a ride.We talk about how her son was misdiagnosed over 15 times (yes, really), why some doctors should come with warning labels, and how American healthcare gaslights patients like it's a competitive sport. She also explains why she's giving away her new book for free, one chapter at a time, and how AI might actually be useful—if it stops hallucinating citations.This is not a light listen. It's the real deal. You'll walk away angry, inspired, and a lot more dangerous as a patient.RELATED LINKSHelene's Substack: https://helenemepstein.substack.comPatient Safety Resources: https://www.pfps.usSociety to Improve Diagnosis in Medicine: https://psnet.ahrq.gov/issue/society-improve-diagnosis-medicineHelene's Website: https://www.hmepstein.com/meet-heleneLinkedIn: https://www.linkedin.com/in/hmepsteinFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform.For guest suggestions or sponsorship inquiries, email podcast@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

In this Episode of the FSR Sarc Fighter podcast, Spring has sprung in Virginia, and John is fueling his optimism for the season with news from the Sarcoidosis world, including a rare disease video series that spotlights sarcoidosis and the announcement of some major grants from FSR to Sarcoidosis researchers.   Show Notes: Watch the video featuring Kerry Wong and Dr. Al on how to deal with Sarcoidosis and talk about it in a meaningful way.  https://bionews.com/keepin-it-rare/ More about the FSR research Grants: https://www.globenewswire.com/news-release/2025/02/03/3019714/0/en/Foundation-for-Sarcoidosis-Research-FSR-Announces-300-000-in-Grant-Funding-to-Improve-Diagnosis-and-Treatment-of-Sarcoidosis.html   MORE FROM JOHN: Cycling with Sarcoidosis http://carlinthecyclist.com/category/cycling-with-sarcoidosis/ Biking 4 Boomers on Tic Tok. https://www.tiktok.com/@biking.4.boomers Do you like the official song for the Sarc Fighter podcast?  It's also an FSR fundraiser! If you would like to donate in honor of Mark Steier and the song, Zombie, Here is a link to his KISS account.  (Kick In to Stop Sarcoidosis)  100-percent of the money goes to the Foundation.  https://stopsarcoidosis.rallybound.org/MarkSteier The Foundation for Sarcoidosis Research https://www.stopsarcoidosis.org/ Donate to my KISS (Kick In to Stop Sarcoidosis) fund for FSR  https://stopsarcoidosis.rallybound.org/JohnCarlinVsSarcoidosis?fbclid=IwAR1g2ap1i1NCp6bQOYEFwOELdNEeclFmmLLcQQOQX_Awub1oe9bcEjK9P1E My story on Television https://www.stopsarcoidosis.org/news-anchor-sarcoidosis/ email me  carlinagency@gmail.com #sarcoidosis #sarcoidosisawareness #

Listen to the top News of 14/01/2025 from Australia in Hindi.

In this podcast, Sian Williams discusses her paper 'Prioritized strategies to improve diagnosis and early management of cerebral palsy for both Māori and non-Māori families'. The paper is available here: https://doi.org/10.1111/dmcn.15847 Subscribe to our channel for more: https://bit.ly/2ONCYiC ___ Listen to all our episodes: https://bit.ly/2yPFgTC __ DMCN Journal: Developmental Medicine & Child Neurology (DMCN) has defined the field of paediatric neurology and childhood-onset neurodisability for over 60 years. DMCN disseminates the latest clinical research results globally to enhance the care and improve the lives of disabled children and their families. DMCN Journal - https://onlinelibrary.wiley.com/journal/14698749 ___ Watch DMCN videos on our YouTube channel: https://bit.ly/2ONCYiC Find us on Twitter! @mackeithpress - https://twitter.com/mackeithpress

This episode of “Inside Health Care: a Podcast by NCQA” features three interviews recorded live at our Health Innovation Summit in October 2023. Among many panels and presentations was an incredible session titled “Health Equity Trailblazers: Where Vision Meets Commitment.” Health equity leaders discussed their organizations' health equity strategies, vision and lessons learned, delving into how leaders can commit to and advance health equity priorities. Each of this episode's guests sat on that panel then sat with me for a deeper dive. These leaders, each in their own way, want to inspire us to action.Dr. Joneigh Khaldun is Vice President and Chief Health Equity Officer for CVS Health. In this role, she advances the company's data-driven strategy to improve access to services, address social determinants of health and decrease health disparities. She is a sought-after speaker and thought leader who has appeared on Meet the Press, MSNBC and CNN, among others, and she has testified before Congress.In her past work, as the top doctor leading Michigan's COVID response, she is credited with the state's early identification of and actions to decrease disparities, and in 2021 was appointed by President Biden to the national COVID-19 Health Equity Task Force. She is a practicing emergency physician who earned her MD from the Perelman School of Medicine at the University of Pennsylvania.Dr. Ronald M. Wyatt is a renowned global health care quality and safety expert with a passion for advancing health equity worldwide. Dr. Wyatt is Founder and CEO of Achieving Health Equity, LLC. As a distinguished Senior Fellow with the Institute for Healthcare Improvement, he holds pivotal roles as Chief Science Officer and Chief Medical Officer at the Society to Improve Diagnosis in Medicine, an organization dedicated to enhancing diagnostic accuracy in health care. As an expert in hospital safety oversight, Dr. Wyatt holds a significant role in shaping the National Patient Safety Goal on Health Equity. His contributions to the National Patient Safety Plan, authored by AHRQ and IHI, underscore his commitment to advancing health care on a global scale.Dr. Bryan O. Buckley moderated the Health Care Trailblazers panel at NCQA's 2nd annual Health Innovation Summit. Dr. Buckley is NCQA's Director for Health Equity Initiatives. In this position, he plays a key role in developing partnerships with funding and research organizations, care delivery systems, the managed care industry and communities to translate research knowledge and real-world evidence into development of equity-oriented products and programs. These include NCQA's Health Equity Accreditation programs.

Bimekizumab in Active AS_ 5 Year Study Deep Neural Networks and Radiographic Progression in AxSpA Difficult to Treat axSpA From AS Patient to Rheumatologist Imaging Updates in SpA INVIGORATE-1 Study_ IV Secukinumab for Treatment of Active axSpA Monitoring the Effect of Therapy with a...Smart Watch_ Overlap of Inflammatory and Degenerative Features in Radiographic axSpA People with AxSpa Need More Sleep Secukinumab vs. Adalimumab Biosimilar on Radiographic Progression in AxSpA SpA Insights_ New Therapies Teledidactic vs On Campus Training in Musculoskeletal Ultrasound Treatments in SpA Undiagnosed IBD in AxSpA Using Telemedicine to Improve Diagnosis of AxSpA

Head to Head Comparison of Tofacitinib and TLL-018 in RA Non-TNFi b_tsDMARDs vs. TNFi in RA-ILD People with RA and Long COVID Had Worse Pre-COVID RA Symptoms Reproductive History, HPV Vaccination Among Women with SLE and  RA Secukinumab vs. Adalimumab Biosimilar on Radiographic Progression in AxSpA The SMART Study_ Split Dose Oral Methotrexate Undiagnosed IBD in AxSpA Using Telemedicine to Improve Diagnosis of AxSpA Window of Opportunity in PsA

In this episode, Dr. Heather Murray, from Queen's University Department of Emergency Medicine presents the landscape of diagnostic errors in emergency medicine from the perspective of why they might occur, what can be done when they happen, and how we might minimize them in the future.    CONTACTS X - @AlwaysOnEM; @VenkBellamkonda YouTube - @AlwaysOnEM; @VenkBellamkonda Instagram – @AlwaysOnEM; @Venk_like_vancomycin; @ASFinch Email - AlwaysOnEM@gmail.com   REFERENCES ARHQ report and responses: December 2022, AHRQ (Agency for Healthcare Research and Quality) released a systematic review on diagnostic error in the ED. https://effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-258-diagnostic-errors.pdf Letter from many ED organizations: Multi-Organizational Letter Regarding AHRQ Report on Diagnostic Errors in the Emergency Department December 14, 2022 Published critical appraisal of report: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10121120/pdf/ms120_p0114.pdf JAMA commentary Feb 2023 “Misdiagnosis in the ED: Time for a System Solution” Misdiagnosis in the Emergency Department: Time for a System Solution | Health Care Safety | JAMA Recovering from error: ARHQ summary on recovery after error Second Victims: Support for Clinicians Involved in Errors and Adverse Events | PSNet ARHQ Commentary – after error:How Do Providers Recover From Errors? | PSNet Clinician Peer Support Program after adverse events – implementation Supporting Clinicians after Adverse Events: Development of a Clinician Peer Support Program - PMC Scott SD, Hirschinger LE, Cox KR, McCoig M, Hahn-Cover K, Epperly KM, Phillips EC, Hall LW. Caring for our own: deploying a systemwide second victim rapid response team. Jt Comm J Qual Patient Saf. 2010 May;36(5):233-40. Caring for our own: deploying a systemwide second victim rapid response team   General resources on Diagnostic Error: Schiff JAMA Network Open 2021Characteristics of Disease-Specific and Generic Diagnostic Pitfalls: A Qualitative Study | Health Policy | JAMA Network Open Monteiro et al. 2020 Review “The enduring myth of generalisable skills.” https://asmepublications.onlinelibrary.wiley.com/doi/full/10.1111/medu.13872 Book – Improving Diagnosis in Health Care (chapter 9) The Path to Improve Diagnosis and Reduce Diagnostic Error   Cognitive biases: MDs were asked to reflect on a serious error and given some education on cognitive biases: Watari, T.; Tokuda, Y.; Amano, Y.; Onigata, K.; Kanda, H. Cognitive Bias and Diagnostic Errors among Physicians in Japan: A Self Reflection Survey. Int. J. Environ. Res. Public Health 2022, 19, 4645. Cognitive Bias and Diagnostic Errors among Physicians in Japan: A Self-Reflection Survey Anchoring Bias and strategies for overcoming: Anchoring Bias With Critical Implications | PSNet "Give me a break!" A systematic review and meta-analysis on the efficacy of micro-breaks for increasing well-being and performance: Albulescu P, Macsinga I, Rusu A, Sulea C, Bodnaru A, et al. (2022) "Give me a break!" A systematic review and meta-analysis on the efficacy of micro-breaks for increasing well-being and performance. PLOS ONE 17(8): e0272460. "Give me a break!" A systematic review and meta-analysis on the efficacy of micro-breaks for increasing well-being and performance | PLOS ONE   Better teams in EM: Purdy E, Borchert L, El-Bitar A et al “Psychological safety and Emergency Medicine team performance: a mixed methods review.” EM Australasia 2023;35:456-465 Psychological safety and emergency department team performance: A mixed‐methods study - Purdy Ottawa M+M rounds framework: Enhancing the Quality of Morbidity and Mortality Rounds: The Ottawa M&M Model - Calder - 2014 - Academic Emergency Medicine - Wiley Online Library   Selected references for artificial intelligence in medicine: AI chatbot in JAMA Internal Medicine Comparing Physician and Artificial Intelligence Chatbot Responses to Patient Questions Posted to a Public Social Media Forum | Health Informatics | JAMA Internal Medicine AI in Health Care NEJM podcast Is Medicine Ready for AI? — ITT Episode 6 | NEJM AI clinical prediction (systematic review 2022) Artificial Intelligence for the Prediction of In-Hospital Clinical Deterioration: A Systematic Review - PMC Lee P, Bubeck S, Petro J. Benefits, limits and risks of GPT-4 as an AI chatbot for medicine. NEJM 2023;388:1233-1239 Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine | NEJM  

Who comes to mind when you picture a ‘diagnostic team'? In this episode we hear from Professor Mark Graber, Founder and President of the Society to Improve Diagnosis in Medicine, as he discusses how improvements in diagnostic accuracy can be achieved by involving other healthcare team members and patients. FURTHER LEARNINGIf you're a member of Medical Protection and want to learn more,please join us for one of our The future of diagnosis webinars: Tuesday 22 August 2023 (HK, SG, MY). Wednesday 23 August 2023 [C&B, UK, IE, ZA]. Wednesday 4 October 2023 (AU). Wednesday 4 October 2023 (NZ). Society to Improve Diagnosis in Medicine: https://improvediagnosis.org/. NAM Report: https://www.ncbi.nlm.nih.gov/books/NBK338596/. John Ely's Checklists: http://tinyurl.com/ElyChecklists. Discussing cases research: https://pubmed.ncbi.nlm.nih.gov/29710111/. Teamwork in diagnosis: https://pubmed.ncbi.nlm.nih.gov/29536943/. TelehealthDecision support: https://pubmed.ncbi.nlm.nih.gov/34642227/. CERTIFICATEA certificate for listening is available on PRISM. https://protection.pub/headliners3SPEAKERS Your host today was Dr Stephen Priestley. https://www.linkedin.com/in/stephen-priestley-854389246/. Our guest speaker today was Dr Mark Graber. https://www.linkedin.com/in/mark-graber-7650a710/ For more information about Medical Protection please visit www.medicalprotection.org

Diagnostic delays and errors are significant contributors to patient illness, injury, and death in the United States. According to the Society to Improve Diagnosis in Medicine, diagnostic errors impact nearly 12 million Americans every year, leading to prolonged hospital stays, increased nonreimbursed healthcare costs, and even more harm when combined with other medical errors. Maureen Madden, DNP, RN, CPNP-AC, CCRN, FCCM, is joined by Mary Jo C. Grant, ACNP, PhD, FAAN, to discuss how to reduce diagnostic delays and errors, with an emphasis on sepsis. This podcast is funded by the Gordon and Betty Moore Foundation through a grant program administered by the Council of Medical Specialty Societies. 0.5 hours of accredited continuing education credit is available for this podcast through March 31, 2024. Visit sccm.org/store and search the podcast name to find details.

Please visit answersincme.com/WPZ860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in hepatology discusses the use of noninvasive tools in the diagnosis and management of nonalcoholic steatohepatitis (NASH). Upon completion of this activity, participants should be better able to: Discuss the role of noninvasive tools in effectively diagnosing and monitoring patients with NASH; Identify strategies to translate real-world evidence on noninvasive tools into clinical practice; and Recognize the impact of timely diagnosis on improving hepatic outcomes in patients with NASH.

Dr. Hiatt's guest this month is Dr. Darya Shlapak. She discusses her article, "Utility of Dual-Energy CT to Improve Diagnosis of CSF Leaks on CT Myelography following Lateral Decubitus Digital Subtraction Myelography with Negative Findings" from the October issue. (17:14)

Suzanne calls up Dr. Doug Salvador, Chief Quality Officer at Bay State Health and Board Member of the Society to Improve Diagnosis in Medicine (SIDM). Suzanne and Doug discuss the prevalence of diagnosis errors, steps to take to learn from them, and how to prevent them in the future. "You need to have some experts, in your organization in diagnosis and the diagnostic process. You need to set up learning systems, where failures of the diagnostic process or these opportunities are identified and reviewed by teams, including patients...you need to put in place standard processes for diagnosis...we need to get better at it overall in health care."

Catching a Break in Fibrodysplasia Ossificans Progressiva: Case-Based Approaches to Improve Diagnosis and Management

Catching a Break in Fibrodysplasia Ossificans Progressiva: Case-Based Approaches to Improve Diagnosis and Management

In this episode of Clinical Conversations Dr Anda Bularga interviews Dr Eoin O'Sullivan about cognitive bias and how it impacts on clinical decision making. Dr Eoin O'Sullivan is a Kidney Research UK Research Fellow at the University of Edinburgh and a Renal Registrar at the Department of Renal Medicine at the Royal Infirmary of Edinburgh. -- Useful Links -- https://twitter.com/eoinrenal Society to Improve Diagnosis in Medicine - https://www.improvediagnosis.org/ -- Follow us -- https://www.instagram.com/rcpedintrainees https://twitter.com/RCPEdinTrainees -- Upcoming RCPE Events -- https://events.rcpe.ac.uk/ Feedback: cme@rcpe.ac.uk

On this episode of Policy Forum Pod, Maria Dahm and Carmel Crock join hosts Sharon Bessell and Arnagretta Hunter to discuss the importance of communication to reaching a correct diagnosis.Diagnostic error is a major issue in Australia, with up to 140,000 people experiencing it every year. But according to new research, the key to changing may not simply be improving doctors' understanding of disease, but actually improving communication between health professionals and patients. So could improving communication actually reduce stress and burnout in the health workforce? And how can the health system and policymakers better respond to these issues? On this episode of Policy Forum Pod, Dr Mary Dahm from The Australian National University (ANU) and Associate Professor Carmel Crock from the Royal Victorian Eye and Ear Hospital and the University of Melbourne join us to discuss how to improve the diagnostic process in Australia.Maria Dahm is Senior Research Fellow at the Institute for Communication in Health Care at The Australian National University and an Honorary Research Fellow at the Centre for Health Systems and Safety Research at Macquarie University.Carmel Crock OAM is Emergency Department Director at The Royal Victorian Eye and Ear Hospital, Chair of the Quality and Patient Safety Committee of the Australasian College for Emergency Medicine, and Chair of the Australia and New Zealand affiliate of the Society to Improve Diagnosis in Medicine.Sharon Bessell is Professor of Public Policy and Director of Gender Equity and Diversity at Crawford School of Public Policy at ANU.Arnagretta Hunter is the Human Futures Fellow at ANU College of Health and Medicine, a cardiologist, physician, and a Senior Clinical Lecturer at ANU Medical School.Find full show notes at policyforum.net. Policy Forum Pod is available on Acast, Apple Podcasts, Spotify, Stitcher, Subscribe on Android or wherever you get your podcasts. We'd love to hear your feedback for this podcast series! Send in your questions, comments, or suggestions for future episodes to podcast@policyforum.net. You can also Tweet us @APPSPolicyForum or join us on the Facebook group. See acast.com/privacy for privacy and opt-out information.

Meet Stacy Hurt, MHA, MBA:Stacy Hurt, MHA, MBA is a Patient Engagement Consultant, Senior Healthcare Advisor for OSP, and is a HIMSS "Digital Influencer." Stacy is also a certified personal fitness trainer, member of the Healthcare Businesswomen's Association, member of the #TelemedNow Thoughtleader group, and member of the Society to Improve Diagnosis in Medicine. Previously, she was a Strategic Partnership Manager for the Colon Cancer Coalition, and spent her early career in the pharmaceutical industry. She received her MHA and MBA from the University of Pittsburgh. Key Insights:Stacy is a cancer survivor, caregiver, digital influencer, and accomplished executive in healthcare. She is paving a new path for patient advocacy and engagement. Giving Patients a Voice. Stacy brings together her personal experience in industry, as a cancer patient, and as an advocate and caregiver to her son, to represent the patient voice is (2:18)The Power of Social Media. Social media is a powerful tool for sharing information and discussing the issues shaping healthcare. It gives patients a voice access to each other as well as to prominent online providers or other healthcare players. (18:50)Advice for Women Leaders. Don't identify about a problem without at least one potential solution, demonstrate that the solution has value, and stand up for yourself – if you feel something is wrong, it probably is. (26:56)This episode is hosted by Ceci Connolly. She is a member of the Advisory Council for Her Story and is the President and CEO of the Alliance of Community Health Plans.Relevant Links:Learn more about Stacy and her work on her websiteFollow Stacy on TwitterConnect with Stacy on Facebook

In this podcast John Piggott discusses his article 'Radiographic technique to improve diagnosis of sagittal axial sesamoid fracture in racing Thoroughbreds with lateral condylar fracture'.

Imagine a computer being able to diagnose cancer better than a team of doctors. That was the promise of artificial intelligence – that it would render human intelligence obsolete one day. But is this more hype than reality? We speak to Prof Ng Kwan Hoong, Medical Physicist and Professor, Department of Biomedical Imaging, University of Malaya, and Dr Evelyn Ho, Consultant Clinical Radiologist, to separate the aspirational aspects of AI from the practical, when it comes to improving imaging and diagnosis of diseases. Image source: Shutterstock

A Growing Trend in Severe Primary Insulin-Like Growth Factor Deficiency Care: Expanding Tools to Improve Diagnosis and Treatment

One of the key numbers to improve your case acceptance is to improve your diagnosis percentage. In today’s episode, we dive into what diagnosis percentage is and why it’s not level all the time. We’ll also discuss why having a thorough and consistent diagnosis process is key to improving case acceptance. This is a big challenge with practices that have multiple hygienists and providers. We also show you the 4 steps to increasing diagnostic consistency so that you have consistent treatment plans to improve the health of your patients. You'll Learn  Why improving diagnosis percentage is key to improved case acceptance The main factor that causes doctors to lower their standard of care The 4 steps to improve diagnostic percentage (and you should NEVER diagnose more than you think is right for the patient) What causes inconsistencies in diagnosis for the same diseases in the mouth and how to fix it The one tool you need to be using to improve your diagnostic standards Why you’re not seeing and diagnosing patient problems that are right in front of you and what to do about it What to do when hygienist and doctors are at odds with each other when it comes to patient diagnosis and treatment The one word is key to make sure everybody is playing on the same team If you haven't already click here to grab our free book "The Ultimate Guide To Doubling Or Tripling Your Dental Practice Production" where we'll show you our 5 step system to explode your practice growth.

Between May 16 - 20th, we took our AiArthritis Voices 360 Talk Show LIVE, to help teach more people who we are, what we do, and how we impact the lives of those affected by AiArthritis Diseases while honoring the 450 million people worldwide living with our diseases. It also served as the starting line for our 2020 fundraising efforts. Differentiating Arthritis Types will help all people, with all types of arthritis, gain more understanding - and possible respect - for their condition, will increase detection and referrals, can lead to improved Quality of Life (QOL) and lower healthcare costs long term. The need to differentiate arthritis types, including the focus on a couple dozen autoimmune diseases and autoinflammatory diseases that include arthritis as a major clinical component.Over 100 autoimmune or autoinflammatory diseases, not all include arthritis. The arthritis is different from other types (like OA or gout). It also can vary in aggressiveness and degree of disease burden. For all, the arthritis differentiates these diseases from the other 100+ and that is why we need to bring light to it.It’s also equally important to teach both the public and practitioners about the differences so they do not dismiss it (i.e. you’re too young to have osteo, OR if you are older that “it’s not OA so it’s nothing) - lending to delays seeking medical attention. In this episode, we expand the conversation from patient-reported issues about the need to differentiate arthritis types to including the rheumatologist point of view. What can patients and rheumatologists do to help educate primary care physicians - and other rheumatologists - to consider the AUTO disease features + arthritis to increase detection, referrals, and diagnosis? How can organizations and patient-focused companies get involved?  This episode builds on prior conversations (The Need to Differentiate Arthritis, Typical vs Atypical, and Diagnosis STAT!) and will expand to include more stakeholder voices as we continue the discussion in future episodes - including Rheumy RoundsⓇ and with other nonprofits from around the world. The end goal is to develop materials to educate the public and practitioners about the AUTO + Arthritis diseases and, in turn, increase awareness, expedite detection and diagnosis, and lower healthcare costs associated with delays. *Rheumy RoundsⓇ is a pilot episode developed by our organization that unites patients and rheumatology professionals at the table - as equals - to discuss issues that, if solved, would improve communication and outcomes.   Who is “at the table”?Dr. Alfred Kim, rheumatologist and Assistant Professor of Medicine and of Pathology & Immunology at Washington University School of Medicine, and founder and director of the Washington University Lupus Clinic.Suz Schrandt is a patient diagnosed decades ago with Juvenile (Rheumatoid, now called Idiopathic) Arthritis and patient engagement advocate with a health and disability law background. She recently launched a new patient engagement initiative called ExPPect and is currently serving as the Senior Patient Engagement Advisor to the Society to Improve Diagnosis in Medicine. Schrandt previously served as Director of Patient Engagement at the Arthritis Foundation, and as Deputy Director of Patient Engagement for PCORI.Tiffany is the CEO at International Foundation for AiArthritis and person living with non-radiographic Axial Spondyloarthritis and other AiArthritis conditions. She uses her professional expertise in mind-mapping, problem solving, and teaching to help others, like her, who live with AiArthritis diseases work in unison to identify and solve unresolved community issues.  AiArthritis Voices 360 is produced by the International Foundation for Autoimmune and Autoinflammatory Arthritis (AiArthritis). Visit us on the web at www.aiarthritis.org/podcast. Find us on twitter, instagram, or Facebook (@ifAiArthritis) or email us (podcast@aiarthritis.org) to have your seat at the table.   

Welcome to AiArthritis Voices 360. This week, join your host, Tiffany, as she and co-host Suz Schrandt talk about the variety of opportunities that exist for patients who want to become active in medical research, education, and advocacy. Regardless of your background, there are opportunities for you to get involved and help shape the future of  medicine and science regarding autoimmune and autoinflammatory arthritis. Your voice matters, and you can make a difference. Pull up a chair to find out how to get started and where your journey could take you. AiArthritis Voices 360 is produced by the International Foundation for Autoimmune and Autoinflammatory Arthritis (IFAA).  Find us on the web at www.aiarthritis.org/podcast, where you can take a seat “at the table” by joining post-episode conversations, nominate future co-hosts, join the official podcast Club and more! Show Notes: Episode 8 – “Where Can Patients Use Their Voice?  Everywhere!” 00:53 – Tiffany welcomes listeners and co-host, Suz Schrandt01:12 – Suz is the Senior Patient Engagement Advisor for the Society to Improve Diagnosis in Medicine (SIDM) and Founder of a patient engagement initiative, ExPPect01:31 – Suz explains the mission of ExPPect04:39 – Suz explains how she got involved with patient engagement07:47 - Tiffany explains how she started working with PCORI (Patient-Centered Outcomes Research Institute)  09:55 - Patient research partners are equal members of research teams10:22 - There are many opportunities to get involved in patient-centered research11:00 - Patients can become ambassadors for PCORI 13:00 - European Patients Academy on Therapeutic Innovation, the European Patients Forum, and the Innovative Medicines Initiative are all European resources for getting involved as a patient researcher14:00 - International Society for Pharmacoeconomics and Outcomes Research (ISPOR) hosts patient representative round-tables all over the globe15:56 - The US Food and Drug Administration (FDA) also has opportunities for patient involvement in the development and approval process for new medications17:06 - Patients can partner directly with pharmaceutical companies to conduct research19:03 - Most of these opportunities include some preliminary training to equip patients with the skills they need to fully participate 20:56  - The US does not have a singular Health Technology Assessment body like many other countries.21:37 - Patients in countries that have an HTA body can serve as co-reviewers to help determine which therapies will be funded24:08 - Instead, the US has the Institute for Clinical and Economic Review (ICER) which has some opportunities for patient participation25:03 - Patients can be Advocates for the American College of Rheumatology 25:37 - Patients can provide input when medical specialty organizations are developing their clinical practice guidelines 27:05 - Patients can serve as Medical Educators by joining local hospital patient and family advisory councils 29:51 - Patient Focused Medicines Development (PFMD) has a repository of people, projects, and best practice guidelines for patient engagement called SYNaPsE 31:13 - Tiffany thanks Suz for coming onto the show to talk about patient engagement opportunities31:26 - Tiffany thanks listeners and invites everyone to visit www.aiarthritis.org/podcast to access resources and provide your thoughts on this topic32:00  - IFAA is recruiting patients to join AiArthritisVoices.org to get involved

In this episode, we speak to the co-founder of the Society to Improve Diagnosis in Medicine (SIDM) Paul Epner to get the skinny on the good, the bad, and the ugly of the diagnostic process and ways of using health IT and patient engagement to improve it, as well as health inequities and social determinants of health that can contribute to misdiagnosis and non-diagnosis, which we hope to expand on in future episodes. We also hear about the humble and surprisingly recent beginnings that led to the impressive current state of SIDM, what inspired its inception, and where it's headed in the future. SHOW NOTES: - SIDM PAIRED Program: Diagnosis: www.improvediagnosis.org/patients-imp…n-diagnosis/ - SIDM Patient Toolkit: www.improvediagnosis.org/patients-toolkit/ BIO: Paul L. Epner, MBA, MEd (Ex-officio) is the Chief Executive Officer and co-founder of the Society to Improve Diagnosis in Medicine (SIDM). He is also the Chair of the Coalition to Improve Diagnosis, a multi-organization collaboration. Paul is a Past President of the Clinical Laboratory Management Association (CLMA) where he also created the Increasing Clinical Effectiveness (ICE) initiative. He is a member of the CDC's “Clinical Laboratory Integration into Healthcare Collaborative,” a consultant to their Laboratory Medicine Best Practices program (an evidence-based practice initiative), and Chair of the Coordinating Council on the Clinical Laboratory Workforce's (CCCLW) Taskforce on Measuring Testing-Related Value. PRODUCED BY: Emily Wittenhagen | Marketing & Communications Manager, Foundation for Health Care Quality THEME MUSIC: Banadu | Seattle, WA: @banadu

Welcome to AiArthritis Voices 360. This episode join your host, Tiffany, as she and co-host Suz Schrandt discuss the importance of early detection and diagnosis. They address barriers to receiving an accurate diagnosis, as well as what patients can do to increase their chances of receiving an accurate diagnosis in a timely fashion. Research consistently shows that early intervention improves patient outcomes. Whether you are a patient looking to confirm the accuracy of your diagnosis or avoid diagnostic delays in the event of new disease onset or a member of the public wondering if you or someone you love could be experiencing the onset of a rheumatological disease, this episode is a must-listen!   AiArthritis Voices 360 is produced by the International Foundation for Autoimmune and Autoinflammatory Arthritis. Find us on the web at www.aiarthritis.org/podcast. Join our online private forum to have your seat at the table.  Show Notes: Episode 6 – “Early Diagnosis” 00:56 – Tiffany welcome listeners and Co-Host Suz Schrandt01:35 – Suz explains Expect, a patient engagement initiative she founded02:44 – The topic for today’s episode is early diagnosis because so many people        experience delays in diagnosis that last months or years04:15 – People frequently receive the wrong rheumatological diagnosis and treatment before discovering the correct one07:15 - Delays lead to regret and distress as people wonder if they could be in remission if they had been diagnosed and received treatment sooner07:48 - Suz’s diagnostic story16:20 - Suz explains Polyarticular, Oligoarticular, and Systemic JIA (3 of the most   common types of Juvenile Idiopathic Arthritis)16:57 - Systemic JIA can be difficult to differentiate from juvenile lupus 19:25 - Clinicians have a tendency to focus on specific symptoms or parts of the body instead of seeing the whole picture, which adds to diagnostic delays 19:40 - Institutional barriers like short appointment times, overcrowded physician schedules, and cost concerns also cause delays in diagnosis20:50 - Some of the hallmark symptoms of arthritis (like pain and fatigue) are invisible 21:17 - People will delay seeking medical help until they exhaust all options to manage symptoms themselves because amongst other things we assume it’s something we can manage or because we’re afraid of navigating the healthcare system23:16 - Early age onset can also contribute to diagnostic delays because the patient appears very healthy 23:29 - Diagnostic delays also occur when medical professionals do not believe patients’ stories24:50 - There are between 40,000 and 80,000 deaths per year in the United States due to delayed and missed diagnoses 25:12 - Age, gender, race, and ethnicity can all cause diagnostic delays25:56 - Patients need to receive all of their test results in a timely fashion and may need to advocate to receive access to them27:27 - Patients do not need positive bloodwork to receive an RA diagnosis, but it is very common for doctors to dismiss patients without supporting bloodwork results29:35 - ACR diagnostic criteria only requires 1 or more swollen joints for more than 6 weeks without another explanation, but many clinicians - especially primary care - do not know that30:26 - If your erythrocyte sedimentation rate (SED rate) is elevated or your RA factor is positive, that can be helpful for a diagnosis, but it is not required31:35 - Testing positive for the HLA-B27 antigen increases the chances that you have ankylosing spondylitis (but some with radiographic changes may not have the gene).32:38 - Suz explains work she has done to teach medical students how to diagnose aiarthritis 35:34 - The work Suz has done to teach practicing clinicians to identify aiarthritis diseases has increased referrals to a rheumatologist by 11% among doctors who completed the training she provides36:30 - Treatment in the first two years is critical to preventing longterm damage and destruction38:22 - You can review the diagnostic criteria for any rheumatological illness on the ACR or EULAR websites and use the information to discuss your concerns with your clinician39:19 - Tracking your symptoms can really help avoid diagnostic delays and maximize the value of your appointment time with your doctor41:13 - SIDM (Society to Improve Diagnosis in Medicine) collects stories from patients of delayed or missed diagnoses 42:23 - Tiffany invites listeners to visit aiarthritis.org/podcast and view the page for this episode to share your diagnosis story with SIDM or view diagnostic criteria on the ACR site43:08 - Tiffany invites listeners to visit aiarthrits.org/voices to register and participate in discussions about this and other important issues surrounding aiarthritis diseases 43:46 - Tiffany thanks Suz for stopping by to discuss early detection and diagnosis of aiarthritis diseases 

Listen NowTwenty years ago last month the National Academy of Sciences published the landmark report, “To Err Is Human, Building a Safer Health System.”  The report found upwards of 98,000 people die each year in hospitals alone as a result of medical errors.  One specific medical error, diagnostic error, was, and remains today, a substantial contributor.  Defined as a wrong, delayed or missed diagnosis, misdiagnoses continue to constitute a major public health problem, adversely affecting more than 12 million annually.  Approximately one-third of whom are seriously harmed and an estimated 40,000 to 80,000 die each year from diagnostic failures in hospitals alone.  Resulting costs are estimated over $100 billion annually.  Despite the problem's pervasiveness and dire effects, the federal government spends less than $10 million annually researching the problem.  (For perspective, the 2019 NIH budget was $39 billion.)   During this 30 minute conversation, Mr. Epner briefly describes the Society to Improve Diagnosis in Medicine's activities, discusses the use/non-use of autopsies in reducing diagnostic errors, the extent to which improved imaging technology is reducing errors and the extent to which this issue is a disparities problem.  He, moreover, discusses efforts to increase funding to address the problem, needed payment reforms, efforts to identify related quality performance measures and recently introduced legislation to improve funding and research.   Mr. Paul L. Epner, MBA, is the Chief Executive Officer and Co-founder of the Society to Improve Diagnosis in Medicine (SIDM).  He is also Chair of the Coalition to Improve Diagnosis, a collaborative with more than fifty of the country's leading healthcare societies, health systems, patient organizations, and organizations focused on improving quality.  He recently was named to the National Steering Committee for Patient Safety.  Mr. Epner is a Past President of the Clinical Laboratory Management Association (CLMA) where he also created the Increasing Clinical Effectiveness (ICE) initiative.  He was recently a member of the CDC's “Clinical Laboratory Integration into Healthcare Collaborative” and a consultant to their Laboratory Medicine Best Practices program (an evidence-based practice initiative).  Mr. Epner is an Associate Editor for the peer-reviewed journal, Diagnosis.Information on SIDM is at: https://www.improvediagnosis.org/. The 2015 National Academy of Sciences expert committee report noted during this interview, "Improving Diagnosis in Health Care," is at: http://www.nationalacademies.org/hmd/Reports/2015/Improving-Diagnosis-in-Healthcare. Recently introduced legislation to address misdiagnoses, i.e., the "Improving Diagnosis in Medicine Act of 2019" (HR 5014), is at: https://www.congress.gov/search?q=%7B%22congress%22%3A%22116%22%2C%22source%22%3A%22legislation%22%2C%22search%22%3A%22HR%205014%20%22%7D&searchResultViewType=expanded.  This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit www.thehealthcarepolicypodcast.com

How can we improve our diagnostic accuracy in Urgent Care?  Dr Matt Wright tells us how frameworks and clinical support tools can help us improve our diagnostic accuracy and ultimately the quality of the care we deliver.   Matt is a FRNZCUC, works in the Emergency Department of Middlemore Hospital and is a member of the RNZCUC executive.  He holds an MBA from Cambridge and outside of his clinical practice he works on quality improvement in Medicine. Below are links to some of the sites and books that Matt mentions in his talk Society to Improve Diagnosis in Medicine https://www.improvediagnosis.org How Doctors Think - Jerome Groopman MD https://www.goodreads.com/book/show/185897.How_Doctors_Think Life in the Fastlane https://litfl.com BMJ Best Practice https://bestpractice.bmj.com/info/ Isabel  https://www.isabelhealthcare.com Up To Date https://www.uptodate.com/home Oxford Handbook of Clinical Medicine online https://oxfordmedicine.com/view/10.1093/med/9780199689903.001.0001/med-9780199689903     www.rnzcuc.org.nz podcast@rnzcuc.org.nz https://www.facebook.com/rnzcuc https://twitter.com/rnzcuc   Music licensed from www.premiumbeat.com Full Grip by ScoreSquad   This podcast is intended to assist in ongoing medical education and peer discussion for qualified health professionals.  Please ensure you work within your scope of practice at all times.  For personal medical advice always consult your usual doctor

When you get sick, you need a diagnosis. If the diagnosis is wrong, the treatment won’t be appropriate. What happens when doctors make diagnostic errors? We talk with a leader in the Society to Improve Diagnosis in Medicine about his recent research. What Diagnostic Errors Are Most Serious? Clinicians make an estimated 12 million diagnostic […]

Go online to PeerView.com/JGG860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert in interstitial lung diseases offers new insights for improving the diagnosis and management of ILD. Upon completion of this activity, participants will be able to: Outline the prevalence, burden of illness, and signs and symptoms of interstitial lung disease (ILD), including IPF and SSc-ILD, Employ updated guidelines and best practices for differential diagnosis of ILD, including IPF, Evaluate current and emerging strategies for the management of ILD, including IPF and SSc-ILD, Implement evidence-based strategies to manage IPF, mitigate adverse events related to antifibrotic therapy, manage comorbid disease, and improve quality of life, Apply methods to effectively communicate and educate ILD patients about their disease.

Go online to PeerView.com/JGG860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert in interstitial lung diseases offers new insights for improving the diagnosis and management of ILD. Upon completion of this activity, participants will be able to: Outline the prevalence, burden of illness, and signs and symptoms of interstitial lung disease (ILD), including IPF and SSc-ILD, Employ updated guidelines and best practices for differential diagnosis of ILD, including IPF, Evaluate current and emerging strategies for the management of ILD, including IPF and SSc-ILD, Implement evidence-based strategies to manage IPF, mitigate adverse events related to antifibrotic therapy, manage comorbid disease, and improve quality of life, Apply methods to effectively communicate and educate ILD patients about their disease.

Go online to PeerView.com/JGG860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert in interstitial lung diseases offers new insights for improving the diagnosis and management of ILD. Upon completion of this activity, participants will be able to: Outline the prevalence, burden of illness, and signs and symptoms of interstitial lung disease (ILD), including IPF and SSc-ILD, Employ updated guidelines and best practices for differential diagnosis of ILD, including IPF, Evaluate current and emerging strategies for the management of ILD, including IPF and SSc-ILD, Implement evidence-based strategies to manage IPF, mitigate adverse events related to antifibrotic therapy, manage comorbid disease, and improve quality of life, Apply methods to effectively communicate and educate ILD patients about their disease.

Go online to PeerView.com/JGG860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert in interstitial lung diseases offers new insights for improving the diagnosis and management of ILD. Upon completion of this activity, participants will be able to: Outline the prevalence, burden of illness, and signs and symptoms of interstitial lung disease (ILD), including IPF and SSc-ILD, Employ updated guidelines and best practices for differential diagnosis of ILD, including IPF, Evaluate current and emerging strategies for the management of ILD, including IPF and SSc-ILD, Implement evidence-based strategies to manage IPF, mitigate adverse events related to antifibrotic therapy, manage comorbid disease, and improve quality of life, Apply methods to effectively communicate and educate ILD patients about their disease.

Go online to PeerView.com/JGG860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert in interstitial lung diseases offers new insights for improving the diagnosis and management of ILD. Upon completion of this activity, participants will be able to: Outline the prevalence, burden of illness, and signs and symptoms of interstitial lung disease (ILD), including IPF and SSc-ILD, Employ updated guidelines and best practices for differential diagnosis of ILD, including IPF, Evaluate current and emerging strategies for the management of ILD, including IPF and SSc-ILD, Implement evidence-based strategies to manage IPF, mitigate adverse events related to antifibrotic therapy, manage comorbid disease, and improve quality of life, Apply methods to effectively communicate and educate ILD patients about their disease.

Go online to PeerView.com/JGG860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert in interstitial lung diseases offers new insights for improving the diagnosis and management of ILD. Upon completion of this activity, participants will be able to: Outline the prevalence, burden of illness, and signs and symptoms of interstitial lung disease (ILD), including IPF and SSc-ILD, Employ updated guidelines and best practices for differential diagnosis of ILD, including IPF, Evaluate current and emerging strategies for the management of ILD, including IPF and SSc-ILD, Implement evidence-based strategies to manage IPF, mitigate adverse events related to antifibrotic therapy, manage comorbid disease, and improve quality of life, Apply methods to effectively communicate and educate ILD patients about their disease.

"Be able to acknowledge the limits of knowledge, be authentic, and invitational to other perspectives on the edge of the unknown" Alexa Miller is an artist and creator of Arts Practica, which builds experiential learning opportunities that allow leaders, practitioners, and teachers in healthcare to be more effective and mindful in uncertainty. She joins us to discuss the incredible rise of her work, the impact it's having, and the ways we can liberate our powers of observation.  Key Learnings 1. A reading and discussion on the importance of a curious spirit 2. Understanding the ripple effect of her work and seeing the lineage grow 3. The rapid growth of art, observation, and medicine and what makes our profession want to be so agile around this topic. 4. Data, impact, and response to using these tools 5. How a tour with Alexa begins and a discussion of the value of space 6. The ways in which art and the power of observation at the edge of uncertainty applies to other industries 7. Being a Fellow for the Society to Improve Diagnosis in Medicine 8. The wonder of dotMD 9. What we should do with liberated energy as a tool for getting better? Links Arts Practica: http://www.artspractica.com Twitter: @artspractica dotMD conference: http://www.dotmd.ie Looking with Uncertainty (Instagram): https://www.instagram.com/lookingwithuncertainty/

Did you know that if you're misdiagnosed then there's a very real chance that you'll also receive the wrong medication?  It's true and on episode #13, writer, author & patient advocate, Helene Epstein, shares her personal stories of family members who not only received the wrong medication but also experienced issues with being overmedicated.  From her father's courageous battle with Parkinson's disease to her beloved son's struggle with an ADHD medication due to misdiagnosis, Helene's story truly embodies what it means to be an empowered consumer navigating our health care system. Show note links: To contact Helene, her helpful tips for parents & patient resources, resources, and more: visit www.hmepstein.com Helene's biography --> Helene serves on the Board of Directors of Brightpoint Health (www.brightpointhealth.org), a nonprofit provider of integrated health care and social support services to the neediest in New York City. As a member of that board, she serves on the Quality Improvement committee. She’s also a member of the Patient Engagement Committee for the Society to Improve Diagnosis in Medicine (SIDM, www.improvediagnosis.org). She also serves as the sole patient advocate expert on the advisory panels for three national studies on diagnostic error. Helene’s been a published writer for over 20 years, is a member of both the American Society of Journalists and Authors (ASJA) and the Association of Health Care Journalists (AHCJ). Starting this Fall, you can read her new column on what patients need to know about getting properly diagnosed. You can also follow Helene on Twitter @HMEpstein

Michael Abramoff, MD, PhD, president, director, and co-founder of IDx, tells how the start-up is using artificial intelligence to better diagnose diabetic retinopathy. The company hopes to get FDA approval of its IDx-DR system.

The power of Artificial Intelligence and Machine Learning looms over Medtech as a growing force that will bring change, good or bad. In this MedtechTalk Podcast, Michael D. Abramoff, MD, PhD, president and co-founder of IDx, tells how the start-up is using AI to better diagnose diabetic retinopathy. The company hopes to secure FDA approval for its IDx-DR system following the completion of clinical trials this summer.

For the second year in a row, Health Innovation Media put a studio on the ground at HIMSS courtesy of the co-founders at Conversa Health Phil Marshall, MD, MBA and West Shell III. We again built an impressive list of guests this year engaging with industry thought leaders, innovators, system executives and the former Acting Administrator for CMS Andy Slavitt. For the compete list checkout:  'LIVE From #HIMSS17: On This Week in Health Innovation'  and for last year's line-up including links to both audio and select video interviews, see: 'LIVE from #HIMSS16: Broadcast Schedule'. Health Innovation Media co-host Douglas Goldstein engages Art Papier MD, CEO VisualDx. Produced by Gregg A. Masters, MPH for Health Innovation Media.

In the realm of mental health, a lack of biologic measures for diagnosing and treating patients has at times made this an area where doctor's subjective decisions can play a disproportionate role. Ehave is seeking to improve diagnosis and treatment of patients with its data-rich management, assessment, and remediation tools that sit on its cloud-based software platform. The company's initial product focuses on ADHD, although it plans to roll-out other applications in the future. We spoke to Prateek Dwivedi, CEO of Ehave, about its platform, the problems the company is trying to address, and how digital technologies are changing the way doctors diagnose, treat, and interact with patients.

There are about 1,000 metabolic disorders, but these genetic rare diseases can go undiagnosed in part because most doctors have so little training in recognizing them. To address this problem, the Genetic Metabolic Center for Education provides both consulting and training in the hopes of improving the diagnosis and care of these patients. We spoke to Mark Korson, medical director of the Genetic Metabolic Center for Education, about the challenges metabolic disorders pose, why so many people go undiagnosed, and how the center is seeking to fundamentally change the way that knowledge is disseminated in the hopes of increasing patient access to a diagnosis and treatment.

The differential diagnosis is at the heart of analytic thinking for the diagnostician.  Dr. Mark Graber agrees.  As the founder of the Society to Improve Diagnosis in Medicine, he should know.  It can overcome many of the biases we are prone to when we limit ourselves only to diagnosis by pattern recognition.  We discuss some simple approaches to generating a differential diagnosis and developing a problem representation.

Host: Matt Birnholz, MD Placenta accreta, also known as invasive placentation, is on the rise in US labor and delivery wards. It’s also potentially deadly, and healthcare professionals need to know how to detect it quickly and manage it safely. Joining Dr. Matt Birnholz at Omnia Education’s Women’s Health Annual Visit in New York to discuss the types, risks, and therapeutic approaches for placenta accreta is Dr. Jordan Perlow, Director of Maternal Fetal Medicine at Banner Good Samaritan Medical Center in Phoenix, AZ, and Associate Clinical Professor of OB/GYN at the University of Arizona School of Medicine.

Host: Matt Birnholz, MD Placenta accreta, also known as invasive placentation, is on the rise in US labor and delivery wards. It’s also potentially deadly, and healthcare professionals need to know how to detect it quickly and manage it safely. Joining Dr. Matt Birnholz at Omnia Education’s Women’s Health Annual Visit in New York to discuss the types, risks, and therapeutic approaches for placenta accreta is Dr. Jordan Perlow, Director of Maternal Fetal Medicine at Banner Good Samaritan Medical Center in Phoenix, AZ, and Associate Clinical Professor of OB/GYN at the University of Arizona School of Medicine.

The Society to Improve Diagnosis in Medicine is seeking to reduce diagnosis errors and the U.S. Bureau of Labor Statistics has released preliminary data from 2011 showing that nearly 17 percent of fatal injuries in the workplace are caused by workplace violence this month on the Chicago Injury Alert.

The Society to Improve Diagnosis in Medicine is seeking to reduce diagnosis errors and the U.S. Bureau of Labor Statistics has released preliminary data from 2011 showing that nearly 17 percent of fatal injuries in the workplace are caused by workplace violence this month on the Chicago Injury Alert. The post Trying to Reduce Diagnosis Errors and Workplace Violence is Cause for Most Fatal Work Injuries – Podcast first appeared on Briskman Briskman & Greenberg.

Spotlight on Multifocal Motor Neuropathy: Strategies to Improve Diagnosis and Treatment

Spotlight on Multifocal Motor Neuropathy: Strategies to Improve Diagnosis and Treatment

Spotlight on Multifocal Motor Neuropathy: Strategies to Improve Diagnosis and Treatment

Spotlight on Multifocal Motor Neuropathy: Strategies to Improve Diagnosis and Treatment

Spotlight on Multifocal Motor Neuropathy: Strategies to Improve Diagnosis and Treatment

Spotlight on Multifocal Motor Neuropathy: Strategies to Improve Diagnosis and Treatment